• By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
In the last 8 hours
Earlier today
In the last 7 days
Statement: Zantac (ranitidine) litigation GlaxoSmithKline (Press Release)15:44 11-Aug-22
EMA business hours over Assumption Day, 15 August European Medicines Agency05:01 11-Aug-22
In the last month
Europe trials new ‘super’ COVID vaccine Emerging Risks03:01 10-Aug-22
Olaparib for high-risk, early-stage breast cancer is approved in Europe European Pharmaceutical Manufacturer04:28 5-Aug-22
EMA extends Covid emergency taskforce for monkeypox Research Professional News07:41 28-Jul-22
EMA response to the monkeypox public health emergency European Medicines Agency06:11 27-Jul-22
CHMP meeting highlights – July 2022 European Pharmaceutical Review04:23 26-Jul-22
EMA recommends restricting use of cancer medicine Rubraca European Medicines Agency06:56 22-Jul-22
Is This Vaccine Stock a Buy After Big News? The Motley Fool06:54 22-Jul-22
Nitrosamine impurities in medicines - Information for sponsors and manufacturers Therapeutic Goods Administration - Australian Government02:48 20-Jul-22
XORTX Announces Submission to European Medicines Agency GlobeNewswire (Press Release)07:04 19-Jul-22
view more headlines
18 Aug 16:23

EMA News

NewsNow brings you the latest news from the world’s most trusted sources on European Medicines Agency. NewsNow aims to be the world’s most accurate and comprehensive EMA news aggregator, bringing you the latest headlines automatically and continuously 24/7. N.B. Relevance is automatically assessed so some headlines not qualifying as European Medicines Agency news might appear - please feel free to contact us regarding any persistent issues.
Read more

Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.